Immunosenescence and vaccine failure in the elderly: Strategies for improving response

被引:55
作者
Boraschi, Diana [1 ]
Italiani, Paola [2 ]
机构
[1] CNR, Inst Prot Biochem, I-80131 Naples, Italy
[2] CNR, Inst Biomed Technol, I-20090 Segrate, Italy
关键词
Vaccination; Elderly; Immunosenescence; T-CELL RESPONSES; INACTIVATED INFLUENZA VACCINES; FLAGELLIN FUSION VACCINE; DENDRITIC CELLS; IMMUNE-SYSTEM; ANTIBODY-RESPONSES; VIRUS HEMAGGLUTININ; HERPES-ZOSTER; OLDER-ADULTS; AGE;
D O I
10.1016/j.imlet.2014.06.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system of the elderly is particularly susceptible to infectious diseases and displays reduced response to vaccination. The current vaccines, designed for young and adult individuals, proved less effective and less protective in old people. The world population is rapidly ageing, and consequently preventing infectious diseases in the elderly have become an important public health issue. To this end, it is necessary to develop novel vaccines especially suited to raising protective immunity in the ageing population. Approaches in this direction include high-dose vaccines, booster vaccinations, different immunisation routes, and use of new adjuvants. These approaches, still empirical, must be supported by intensive research to unravel the biological and molecular mechanisms underlying immunosenescence. Only this knowledge would allow us to design approaches to immune rejuvenation and more effective vaccines for protecting the elderly. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:346 / 353
页数:8
相关论文
共 124 条
[1]   Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging [J].
Agius, Elaine ;
Lacy, Katie E. ;
Vukmanovic-Stejic, Milica ;
Jagger, Ann L. ;
Papageorgiou, Anna-Pia ;
Hall, Sue ;
Reed, John R. ;
Curnow, S. John ;
Fuentes-Duculan, Judilyn ;
Buckley, Christopher D. ;
Salmon, Mike ;
Taams, Leonie S. ;
Krueger, James ;
Greenwood, John ;
Klein, Nigel ;
Rustin, Malcolm H. A. ;
Akbar, Arne N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (09) :1929-1940
[2]  
Agrawal A, 2012, EXPERT REV CLIN IMMU, V8, P73, DOI [10.1586/eci.11.77, 10.1586/ECI.11.77]
[3]   The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination [J].
Ambrose, Christopher S. ;
Wu, Xionghua ;
Belshe, Robert B. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (09) :806-811
[4]  
[Anonymous], 2002, WORLD POPULATION AGE
[5]   Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60 Evaluation of immunogenicity, cross-protection, safety and tolerability [J].
Ansaldi, Filippo ;
Orsi, Andrea ;
de Florentiis, Daniela ;
Parodi, Valentina ;
Rappazzo, Emanuela ;
Coppelli, Martina ;
Durando, Paolo ;
Icardi, Giancarlo .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (03) :591-598
[6]   A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years [J].
Antrobus, Richard D. ;
Lillie, Patrick J. ;
Berthoud, Tamara K. ;
Spencer, Alexandra J. ;
McLaren, James E. ;
Ladell, Kristin ;
Lambe, Teresa ;
Milicic, Anita ;
Price, David A. ;
Hill, Adrian V. S. ;
Gilbert, Sarah C. .
PLOS ONE, 2012, 7 (10)
[7]   Gain and Loss of T Cell Subsets in Old Age-Age-Related Reshaping of the T Cell Repertoire [J].
Arnold, Christoph R. ;
Wolf, Juliane ;
Brunner, Stefan ;
Herndler-Brandstetter, Dietmar ;
Grubeck-Loebenstein, Beatrix .
JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (02) :137-146
[8]   Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents [J].
Baldo, Vincenzo ;
Baldovin, Tatjana ;
Pellegrini, Michele ;
Angiolelli, Gabriele ;
Majori, Silvia ;
Floreani, Annarosa ;
Busana, Marta Cecilia ;
Bertoncello, Chiara ;
Trivello, Renzo .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
[9]   Stem cells and the aging hematopoietic system [J].
Beerman, Isabel ;
Maloney, William J. ;
Weissmann, Irving L. ;
Rossi, Derrick J. .
CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (04) :500-506
[10]   GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults [J].
Behzad, Hayedeh ;
Huckriede, Anke L. W. ;
Haynes, Laura ;
Gentleman, Beth ;
Coyle, Krysta ;
Wilschut, Jan C. ;
Kollmann, Tobias R. ;
Reed, Steven G. ;
McElhaney, Janet E. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (03) :466-473